Maharashtra Ramping up Manpower, to Appeal Against NMC Rejection for Proposed GMCs

Mumbai: After the National Medical Commission’s (NMC) rejection to approve the proposed government medical colleges in Maharashtra, the State Government is ramping up the manpower as it is planning to appeal before the Commission in this regard.

Confirming this, a senior official from the State Medical Education Department told Indian Express, “We will appeal against the decision. Simultaneously, we are ramping up manpower.”

The Department is planning to fill up the faculty positions on a contractual basis and aims to fill up at least 30% of the 800 pending positions of Assistant Professors, 167 positions of Associate Professors, and 400 positions of Professors.

Medical Dialogues recently reported that only two out of twelve medical colleges in Maharashtra have received the National Medical Commission’s (NMC) approval for starting new medical colleges.

While altogether 10 government-run medical colleges had submitted proposals to the Apex Medical Commission for starting new medical institutes, NMC approved only one. This newly approved government medical college will come up on the common campus of Gokuldas Tejpal (GT) and Cama hospitals in the Fort area. Besides this government medical college, NMC has also approved a private deemed university based in Nerul, i.e., MGM Institute of Health Sciences, to start operating from 2024-2025. Even though MGM Institute had applied for NMC permission for 100 MBBS seats, the Commission approved 50 MBBS seats. Both institutes will offer 50 MBBS seats.

Also Read: NMC Nod to Only 2 out of 12 New Medical Colleges In Maharashtra

On the other hand, the Commission rejected the proposals of medical colleges in Jalna, Bhandara, Washim, Buldhana, Gadchiroli, Nashik, Amravati, Ambernath, and Hingoli districts as these institutes failed to meet the essential standards set by NMC. In the case of SIMS Aurangabad, the institute was issued a notice regarding the deficiencies and was asked to comply with the prescribed norms within 15 days.

As per the latest media report by Indian Express, the rejection on the part of the NMC was primarily because of inadequate facilities in rural areas including lack of clean drinking water and insufficient infrastructure. Currently, the State is planning to address these shortcomings and reapply before the Commission for its approval. 

“We are committed to meeting all conditions set by the commission,” a senior department official told the Daily.

Meanwhile, commenting on the matter, the Secretary of the Medical Education Department, Dinesh Waghmare highlighted that the shortage of skilled manpower was a key reason for NMC’s rejection of the proposals. He added, “If necessary, we will arrange contractual manpower.”

In order to ensure that there is an adequate number of staff in the newly established rural medical colleges such as Gadchiroli, Hingoli, and Jalna, the State is considering transferring professors from the existing medical colleges. However, such participations will be voluntary in nature.

Currently, there are around 8,000 MBBS seats available in Maharashtra. Addition of 800 medical seats in the new medical colleges is aimed to enhance the healthcare access in the State. In this regard, the State Government has allocated approximately Rs 97 crore from its supplementary budget to staff and equip these new institutes.

Recently the Maharashtra Medical Education Minister Hasan Mushrif also stated that the Government was trying to start 10 new medical colleges in the State from this academic year. 

he had also mentioned that an appeal would be filed with the NMC for the proposed nine GMCs, adding that efforts were being made to obtain permission for these colleges by submitting an undertaking regarding the commission of errors by the government at the hearing of this appeal.

Also Read: Maharashtra to file appeal before NMC for proposed 9 GMCs

Powered by WPeMatico

Sandoz unveils biosimilar Pyzchiva across Europe to treat chronic inflammatory diseases

Basel: Sandoz has announced the launch of Pyzchiva (ustekinumab) across Europe. Pyzchiva, developed and registered by Samsung Bioepis, a ustekinumab biosimilar to launch in Europe with all reference medicine strengths, including the 130mg vial initiation dose for Crohn’s disease.

“The launch strengthens our well-established immunology portfolio in Europe and leverages our existing footprint, with five biosimilars now marketed in this therapeutic area,” the Company stated.

Rebecca Guntern, President Europe, Sandoz, said, “Timely and expanded access to safe, effective and affordable medicines can improve quality of life for millions of people living with chronic inflammatory diseases. Our goal is to make potentially life-changing medicines accessible to patients across Europe. Pyzchiva is one of the first ustekinumab biosimilars in Europe, which marks a significant milestone on that road.”

Pyzchiva is approved for treatment of adults with plaque psoriasis, psoriatic arthritis, Crohn’s disease and pediatric plaque psoriasis for patients six years and older weighing over 60 kg.

Europe has the highest prevalence of psoriasis worldwide, affecting an estimated 6.4 million people and significantly impacting patients’ quality of life. Plaque psoriasis is the most common form of psoriasis, affecting 85% to 90% of patients with psoriasis.

Sandoz entered into a development and commercialization agreement for biosimilar ustekinumab with Samsung Bioepis in September 2023. Under the terms of the agreement, Sandoz has the right to commercialize Pyzchiva in the US, Canada, the European Economic Area, Switzerland, and the UK. Samsung Bioepis remains responsible for development, registration, intellectual property, manufacturing, and supply.

Pyzchiva is a trademark of Samsung Bioepis Co. Ltd. Stelara is a trademark of Johnson & Johnson.

Pyzchiva (ustekinumab) has been developed as a biosimilar with equivalent efficacy and comparable safety to the reference medicine Stelara, a human monoclonal antibody against interleukin (IL)-12/23. 

Pyzchiva is available as a 130 mg concentrate in a vial for solution for infusion, additionally, a 90 mg and a 45 mg concentrate solution for injection in a pre-filled syringe.

Read also: Sandoz confirms European Commission nod of Pyzchiva

Powered by WPeMatico

Manipur boy with severe scoliosis undergoes spine surgery at Fortis Hospital Greater Noida

Greater Noida: A highly challenging spine surgery on a 14-year-old boy from Manipur, India was successfully conducted to correct severe scoliosis at Fortis Hospital Greater Noida. 

The complex procedure, which spanned five hours, involved the removal of a hemivertebra—a half-formed vertebra in the spine. This type of surgery is technically demanding as it requires the precise correction of scoliosis while ensuring the protection of the surrounding nerves. Given the high risk of paralysis associated with this surgery, it had been previously turned down by several major hospitals in India.

The surgery was conducted to correct severe scoliosis, under the expert guidance of Dr Himanshu Tyagi, with Dr Rajesh Mishra and Dr Mohit Sharma as the lead surgeon. The complex procedure, which spanned five hours, involved the removal of a hemivertebra—a half-formed vertebra in the spine.

Also Read:Doctors at Fortis Vasant Kunj remove tennis-ball-sized facial nerve schwannoma from 39-year-old Kenyan woman

Dr Himanshu Tyagi, Additional Director of Orthopedics and Spine, Fortis Hospital Greater Noida expressed his pride in the team’s achievement, stating, “This surgery was particularly challenging due to the complexity of removing a half-formed vertebra while protecting the spinal nerves. The success of this procedure highlights the advanced medical capabilities and dedication of our team at Fortis Hospital.”

Dr Praween Kumar, CEO of Fortis Hospital Greater Noida, added, the successful execution of this surgery was made possible by the advanced ICU backup and the presence of an expert team of anesthetists at Fortis Hospital. The patient, who faced a significant risk of paralysis, is now doing remarkably well. Just days after the surgery, the boy is walking around, climbing stairs, and showing no signs of neurological complications.

The patient’s family expressed their gratitude to the medical team at Fortis Hospital Greater Noida for taking on this challenging case and providing their son with a new lease on life. This successful surgery marks a significant advancement in the field of spinal surgery and reinforces Fortis Hospital’s commitment to providing cutting-edge medical care

Powered by WPeMatico

Dereliction of duty! HC Denies Relief to Medical Officer Who Submitted False Injury Report, Compulsory Retirement upheld

Jaipur: Denying relief to a Medical Officer, who had committed dereliction of duty by submitting a factually wrong injury report in a case, the Rajasthan High Court upheld the compulsory retirement as a punishment for the doctor.

Noting that the doctor submitted a false report and terming such conduct as “highly despicable”, the HC bench held, “In view of the aforesaid findings, it is apparent that the petitioner has submitted false report and committed dereliction in discharge of his duty. None can undermine the importance of true and correct medico-legal report in the injury cases which has great role in just and fair disposal of the cases. Such a conduct by the Medical Officer is highly despicable as it causes interference with the administration of justice.”

Upholding the disciplinary action of compulsory punishment for the doctor, the HC bench comprising Justice Mahendar Kumar Goyal noted, “In view thereof, this Court does not find the punishment awarded to the petitioner by the disciplinary authority based on concurrence of the RPSC to be shockingly disproportionate to the conscience so as to warrant interference of this Court under its limited writ jurisdiction.”

The petitioner was accused of furnishing wrong facts in the injury report prepared upon medical examination of a person while he was posted as a Medical Officer at the Community Health Centre, Toaraisingh (Tonk). Following this, he was served with a charge sheet under Rule 16 of the Rajasthan Civil Services (Classification, Control & Appeal) Rules, 1958 through the Memorandum dated 17.01.1998 for committing dereliction of his duty.

An inquiry was held according to the procedure prescribed under Rule 16 of the Rules of 1958 and he was found guilty by the Inquiry Officer. Consequently, the disciplinary authority, agreeing with the findings of the Inquiry Officer, punished him through an order dated 30.03.2002 with the punishment of compulsory retirement with a proportionate pension.

Filing the plea, the concerned Medical Officer sought quashing of the charge-sheet dated 17.01.1998 against him, the concurrence letter dated 04.03.2002 issued by the Rajasthan Public Service Commission, Ajmer, the order of punishment dated 30.03.2002 and the consequential relieving order dated 16.04.2002 with a further direction to the respondents to allow him to continue on the post of Junior Specialist (Anesthesia). However, during oral submissions, the counsel for the petitioner confined his prayer to the extent of modification of punishment.

Challenging the quantum of the punishment, the counsel for the petitioner doctor submitted that he measured the dimension of injuries received by the patient through the naked eye which might have resulted in some variation.

He submitted that before being ordered the punishment, he had rendered the services for 23 years and considering the nature of the allegation found to be proved against him, the punishment of compulsory retirement with a proportionate pension was highly disproportionate. Therefore, he prayed for modification of the punishment by substituting it with a lighter punishment.

On the other hand, opposing the prayer, the State Counsel submitted that the punishment awarded to the petitioner doctor was on the lighter side taking a lenient view of the matter which did not warrant any interference of the Court. Therefore, the State Counsel prayed for the dismissal of the plea.

While considering the matter, the HC bench perused the material on record that revealed a great variance in the injury report prepared by the petitioner with the medical report prepared by the Medical Board. The bench observed that while the petitioner found the injury No.1, a sharp-edged injury on the shoulder of the injured to be 3 centimeters in length, the Medical Board found the same to be four and a half inches i.e. 11.25 centimeters in length. 

Similarly, while the petitioner doctor found injury No. 2, another sharp-edged injury on the head of the injured 2 centimeters, the Medical Board found it to be 1.25 inches i.e. 3.75 centimetre in length.

Taking note of these findings, the bench observed that the petitioner doctor had submitted a false report and committed dereliction in the discharge of his duty. Highlighting that noone can undermine the importance of true and correct medico-legal reports in injury cases which has a great role in the just and fair disposal of the cases, the HC bench termed the conduct of the Medical Officer as highly despicable as it caused interference with the administration of justice.

“In view thereof, this Court does not find the punishment awarded to the petitioner by the disciplinary authority based on concurrence of the RPSC to be shockingly disproportionate to the conscience so as to warrant interference of this Court under its limited writ jurisdiction,” observed the bench while dismissing the doctor’s plea.

To view the order, click on the link below:

https://medicaldialogues.in/pdf_upload/rajasthan-hc-wrong-medico-legal-report-244615.pdf

Also Read: Dereliction of Duty: Medical Officer faces suspension, another under radar of JnK Health Dept

Powered by WPeMatico

Non-acceptance of thesis could be possible reason for GMC Patiala Anaesthesia Medico suicide, Resident Doctors demand fair probe

Patiala: Following the suicide of final year PG anaesthesia medico due to alleged duty stress and academic workload, the resident doctors of Government Medical College and Rajindra Hospital, Patiala, have urged the college authorities to conduct a fair investigation and demanded the inclusion of their members in the internal fact-finding committee to ensure transparency.

In a memorandum handed over to the acting director principal of the medical college hospital Dr. Ashwani Kumar by the delegation led by Dr Akshay Seth and Dr Nrip Jindal, the Residents Doctors Association (RDA) called for immediate action and a fair and transparent investigation into the doctor’s death case.

Also read- Duty Stress, Academic Workload: GMC Patiala MD Anaesthesia Medico Commits Suicide

“Given the seriousness of these concerns, we urge you to reconsider our request and include members from the resident doctors’ association in the inquiry committee. Failing to do so will compel us to escalate the matter further,” mentioned the memorandum as reported by The Tribune

Medical Dialogues team had previously reported that a final year PG anaesthesia medico at Government Medical College (GMC) Patiala allegedly committed suicide by injecting an unidentified harmful substance in her hostel room. According to the police, the doctor was struggling with depression and was under extreme academic stress over her thesis leading her to take the extreme step of administering something “poisonous” with an injection into her body.

The 29-year-old student from Chennai, Tamil Nadu was receiving treatment for stress related to her academic and professional work pressure. She was finding it challenging to manage her academic workload and had requested a break to concentrate on finishing her thesis as she was also overwhelmed by her work duties.

In response to the incident, the RDA expressed concerns about the current investigation process, citing reports that resident doctors were being discouraged from providing statements. 

In a communique, the association stated, “There are reports that some resident doctors are being discouraged from providing statements regarding this case (suicide), which raises concern about transparency and fairness.”

In a letter to the college administration, the RDA expressed concerns about the current investigation process, citing reports that resident doctors were being discouraged from providing statements. “This raises significant concerns about the transparency and fairness of the investigation,” the communique stated.

Earlier, the police investigating the case stated that the victim was preparing her thesis for her postgraduate studies. However, she was upset that her thesis was not accepted because the computer on which she had saved the file for her thesis crashed, and she had to make the thesis all over again. The police discovered during the preliminary investigation that the thesis was supposed to be submitted by July 15. Unfortunately, she had to redo it, leading to its rejection and causing her distress.

Also read- NIMS Anaesthesia Professor Ends Life By Injecting Self With Drug

Powered by WPeMatico

Zydus Life Sciences Gets CDSCO Panel Nod to Study anti-cancer drug Relugolix

New Delhi: The drug major Zydus Lifscience has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct a Phase-IV clinical trial of the anti-cancer drug Relugolix Tablets 120 mg.

This came after Zydus Lifesciences presented the proposal for a grant of permission to conduct a Phase-IV clinical trial of Relugolix 120 mg tablets along with Phase-IV clinical trial protocol (Protocol No. 24-01, Version:00, Dated:12.01.2024) before the committee.

The firm informed that CDSCO already issued permission vide No. MF-ND-54/2023 dated 16.10.2023 for the manufacture and marketing of Relugolix 120 mg tablets in the country with the condition of conducting a Phase IV clinical trial.

Relugolix is in a class of medications called gonadotropin-releasing hormone (GnRH) receptor antagonists. It works by decreasing the amount of testosterone (a male hormone) produced by the body.

Relugolix is used in men to treat advanced prostate cancer. Relugolix is a type of medicine called a gonadotropin-releasing hormone (GnRH) antagonist. It helps treat prostate cancer by lowering the amount of testosterone hormone in the blood. In some patients, testosterone will cause prostate cancer to grow larger.

The mechanism of action of relugolix is as a gonadotropin-releasing hormone receptor antagonist, a cytochrome P450 3A inducer, a cytochrome P450 2B6 inducer, and a breast cancer resistance Inhibitor, P-Glycoprotein inhibitor. The physiologic effect of relugolix is by means of decreased GnRH secretion.

Earlier, the Medical Dialogues Team had reported that the Central Drug Standard Control Organization (CDSCO) had approved Zydus Lifescience to manufacture and market Relugolix Tablets 120 mg indicated for the treatment of adult patients with advanced prostate cancer, with local Phase III clinical trial waiver subject to the condition that firm should conduct Phase IV clinical trial within 3 months of approval.

In continuation, at the recent SEC meeting for oncology held on July 9, 2024, the expert panel reviewed the proposal for the grant of permission to conduct a Phase-IV clinical trial of Relugolix 120mg Tablets along with Phase-IV clinical trial protocol (Protocol No. 24-01, Version:00, Dated:12.01.2024).

After detailed deliberation, the committee recommended granting permission to conduct a Phase IV clinical trial of Relugolix 120 mg tablets as per the protocol presented by the firm.

Also Read: CDSCO Panel Approves Johnson and Johnson’s Protocol Amendment Proposal to Study JNJ-77242113

Powered by WPeMatico

Illegal Nursing Homes: Delhi Govt seeks details of 7 officials for probe

The Delhi government has instructed the Directorate General of Health Services (DGHS) to provide detailed information about seven officials as part of a vigilance investigation into suspected irregularities and unlawful registration practices at private nursing homes.
According to a PTI report, the health department, in a communication to the Directorate General of Health Services, Delhi, said the Directorate of Vigilance has sought detailed biodata of seven officers, “along with specific recommendations containing role and responsibilities of each accused officer” in the matter.
For more information click on the link below:

Powered by WPeMatico

Union Health Budget 2024: Minimal funding increase for 3 central govt hospitals

The central government-run hospitals in the national capital received a slight increase in budget allocation in the recent union budget presented by Finance Minister Nirmala Sitharaman, compared to the previous year.
On Tuesday, the minister announced the budget allocation of three central government hospitals including All India Institute of Medical Sciences (AIIMS) Delhi, Ram Manohar Lohia (RML), and Lady Hardinge Medical College (LHMC).
For more information click on the link below:

Powered by WPeMatico

NMC directs all medical colleges to upload faculty list by July 31st

Through a recent notice, the Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has directed all medical colleges to upload the faculty list by 31st July 2024.
The Commission has further asked the medical institutes to update the faculty list every month. It specified that the deadline for such updating shall be the last day of every month.
For more information click on the link below:

Powered by WPeMatico

UP MBBS Interns Demand Stipend Hike from Rs 12,000 to Rs 30,000 per Month, Boycott Duties in Protest

Lucknow: The MBBS interns in Uttar Pradesh Government Medical Colleges across 14 districts of the State have been protesting against the meagre amount of stipend they receive during their internship programme.

For the last five days, the medicos have been boycotting their hospital duties demanding a stipend hike. Claiming that they receive the lowest stipend i.e. Rs 12,000 per month across the country, the UP MBBS Interns have demanded that the amount should be raised to at least Rs 30,000 per month.

As per the National Medical Commission’s (NMC) rules, it is mandatory for MBBS students to undergo one year of compulsory internship to get their medical degrees and start practice in India. During the period of internship, the Interns receive a stipend provided by the Government (in case of Government Medical Colleges) or the Institutes (private medical institutes).

The UP MBBS Interns have pointed out that the Rs 12,000 per month stipend equals Rs 400 per day, which according to the doctors is even lesser than wage of “unskilled labourers”. They have demanded that the stipend should be increased to Rs 30,000 per month i.e. Rs 1000/day.

Also Read: Rajasthan Private Medical Colleges Paying MBBS Interns, Resident doctors Far Lesser than Govt Mandate: Reveals RTI

Raising the issue, the President of the All India Medical Students Association (AIMSA) Dr Jitendra Singh recently pointed out that the current amount of stipend paid by to the MBBS interns by the UP Government is the lowest across the country. “Most of the private colleges interns are underpaid and not even paid. The Stipend to Interns should be paid equally,” Dr. Singh mentioned in an X (formerly Twitter) post.

Extending support to the protesting medicos, AIMSA recently issued a Press Release and mentioned how protest rallies are being taken out and demonstrations are being held in all the medical colleges and universities of Uttar Pradesh to increase the stipend for MBBS Interns, who have decided not to go to work until their monthly stipend is increased. 

The association further pointed out that all the intern doctors and MBBS students of AIMSA have expressed their demands that considering the inflation, the stipend should be increased to Rs 30,000 per month, which is currently Rs 12000 per month and the lowest amount paid to the MBBS interns across the country.

In the release, Dr Jitendra Singh further referred to the earlier letter written by AIMSA to Chief Minister Yogi Adityanath and Health Minister Shri Brajesh Pathak.

Writing to the Chief Minister and the Health Minister of the State, AIMSA on 23.07.2024 had mentioned, “Medical interns are an indispensable part of the healthcare system. They work diligently and shoulder significant responsibilities in hospitals and healthcare centers, often managing critical patient care alongside their senior colleagues. Their commitment and contribution are vital to the smooth functioning of healthcare services, especially in these challenging times. Despite their hard work and dedication, the current stipend provided to medical interns in Uttar Pradesh is insufficient to cover their basic living expenses and professional needs.”

Pointing out how several other states recognized the value of their medical interns and accordingly increased their stipend amounts, the association had urged the Government to consider a revision and increase in the stipend for medical interns in Uttar Pradesh, adding that “Such a measure will provide much-needed financial support, allowing these young professionals to focus wholeheartedly on their training and duties, ultimately benefiting the healthcare delivery system of our state.”

Sharing the copy of the letter, AIMSA had earlier warned that if the demands of UP MBBS Interns were not met, it would run a Pan India Campaign.

Meanwhile, the photos of videos of the protesting medicos are doing rounds on the Internet. The students are seen raising slogans like “400 rupiya Majdoori hai, ye hartal zaroori hai”, “we want justice”. 

Dr Jitendra Singh in a recent X (Twitter) post had mentioned that the representatives of the association along with the medical students (interns) from UP would meet the Deputy Chief Minister of UP Brajesh Pathak to discuss about the issue.

ABVP Delegation Meets Deputy CM: 

Meanwhile, a delegation of Akhil Bharatiya Vidyarthi Parishad (ABVP) on Friday submitted a memorandum to UP Deputy Chief Minister Brijesh Pathak, demanding an increase in the stipend of medical interns. Pathak is handling the Health and Medical Education Department in the Uttar Pradesh government, PTI has reported. 

The ABVP said medical interns are not given stipend according to their requirement in the regional medical institutes and medical schools, for which the students are agitating to increase it and ABVP is with them in this demand. It had also informed Brijesh Pathak about this problem on July 17, the ABVP said in a statement issued here.

ABVP State Media Coordinator Abhinav Mishra said during the discussion on these points with their delegation, Pathak assured that this matter will be seriously considered and a decision will be taken in the interest of the medical students. Another office-bearer of the RSS’ student wing, Rohit Singh said, “The ABVP has been continuously demanding that a uniform stipend be fixed for medical students across the country. In Uttar Pradesh, medical interns are given Rs 12,000 as stipend which is not sufficient for their basic needs.”

ABVP Convenor and medical intern Saurabh Nayak said, “While in the other states, an average of Rs 25,000 is given as stipend to the medical interns, this amount is Rs 12,000 in Uttar Pradesh.”

The issue of stipends paid to the MBBS interns is also being considered by the Supreme Court. Medical Dialogues had earlier reported that during the hearing of the issue earlier this year, the Supreme Court had directed NMC to submit the details of the stipend paid to the MBBS interns in all the medical colleges across all States within four weeks.

Accordingly, complying with the Supreme Court’s directions, NMC recently asked the medical colleges to submit the details of the stipend paid to the medical students for the academic year 2023-2024. NMC had directed medical colleges to submit the details of their name and address, the amount of stipend paid by the State Government, and the month-wise details of the stipend paid to the MBBS interns, 1st/2nd/3rd-year Post-Graduate Residents, and 1st/2nd/3rd-year Senior Residents or PGs in Super Specialty for the academic year 2023-2024.

The Supreme Court bench took cognisance of the issue while considering a plea filed by five MBBS students studying at Army College of Medical Sciences (ACMS) affiliated with Guru Govind Singh Indraprastha University seeking a stipend for the period of internship.

While considering the plea filed by ACMS students, the top court bench had directed the medical college to start paying its Interns Rs 25,000 per month from October 1, 2023. During the hearing of the case, the counsel for the students Advocate Vaibhav Gagghar informed the bench that a recent NMC report stated that 70 per cent of the medical colleges in the country were not paying stipends to their interns.

Taking note of this, the bench directed the National Medical Commission’s counsel Advocate Gaurav Sharma to respond to the claim and file an affidavit.

Also Read: Now MBBS interns at Private Medical Colleges in Maharashtra to get Rs 18k stipend

Powered by WPeMatico